Page 2 - Gates Ventures News Today

Bionaut Labs, already backed by VCs like Khosla and Upfront, now has buy-in from the Mayo Clinic, where later this year the company’s medical micro-robots will go into clinical trials.

Announces Expanded Multi-Year Software Agreement with Lilly Continued Focus in 2024 on Advancing Science Underlying Platform, Driving Software Adoption and Progressing Proprietary Pipeline ...

AI can be used to improve productivity and expand access to education, mental health care and more, Bill Gates writes.

The Institute for Research and Education to Advance Community Health has received $250,000 in funding to lead a study on the participation of American Indian and Alaska Native people in Alzheimer’s disease clinical trial research.

“Our collaboration with GH Labs will focus on bringing innovative health-tech solutions to the last mile, where they have the highest potential for impacting the underserved. The goal is to make a meaningful impact on the public healthcare system, in a way that bridges the accessibility to affordability gap on quality healthcare for Bharat," Krishna Mathur, director-ACT For Health, said in a press note.

ACT, a philanthropic organization based in India, and Global Health Labs , Inc. (GH Labs), an international non-profit funded by...

This Viewpoint considers AI’s limits in solving the medical billing quagmire and argues that standardizing health insurance claim forms and simplifying billing

Discover the top mobile app development companies in the USA for 2023. Explore industry leaders known for their cutting-edge solutions.

Bill Gates has acquired 1.7 million shares of Anheuser-Busch Inbev through the Bill and Melinda Gates Foundation trust during the second quarter of this year. The billionaire may have made the investment on the hopes that the company can get past its Bud Light fiasco, or he may think its new brand image fits with his infamous reputation as an "office bully" and friend of Jeffrey Epstein.

Bill Gates has acquired 1.7 million shares of Anheuser-Busch Inbev through the Bill and Melinda Gates Foundation trust during the second quarter of this year. The billionaire may have made the investment on the hopes that the company can get past its Bud Light fiasco, or he may think its new brand image fits with his infamous reputation as an "office bully" and friend of Jeffrey Epstein.